Key result
Among patients admitted with acute decompensated heart failure in a Malaysian non-cardiology tertiary center, the in-hospital mortality was 7.5% and 90-day all-cause mortality was 16.8%.
Why the study?
Data on the clinical characteristics of acute decompensated heart failure in Malaysia, particularly in East Malaysia, are lacking.
Observational (n=107)
No
ADHF patients in East Malaysia have high short-term mortality and readmission rates, potentially driven by low evidence-based medication prescription and high prevalence of cardiovascular risk factors in younger patients.
BACKGROUND: Data on clinical characteristics of acute decompensated heart failure (ADHF) in Malaysia especially in East Malaysia is lacking. METHODS: This is a prospective observational study in Sarawak General Hospital, Medical Department, from October 2017 to September 2018. Patients with primary admission diagnosis of ADHF were recruited and followed up for 90 days. Data on patient's characteristics, precipitating factors, medications and short-term clinical outcomes were recorded. RESULTS: Majority of the patients were classified in lower socioeconomic group and the mean age was 59 years old. Hypertension, diabetes mellitus and dyslipidaemia were the common underlying comorbidities. Heart failure with ischemic aetiology was the commonest ADHF admission precipitating factor. 48.6% of patients were having preserved ejection fraction HF and the median NT-ProBNP level was 4230 pg/mL. Prescription rate of the evidence-based heart failure medication was low. The in-patient mortality and the average length of hospital stay were 7.5% and 5 days respectively. 43% of patients required either ICU care or advanced cardiopulmonary support. The 30-day, 90-day mortality and readmission rate were 13.1%, 11.2%, 16.8% and 14% respectively. CONCLUSION: Comparing with the HF data from West and Asia Pacific, the short-term mortality and readmission rate were high among the ADHF patients in our study cohort. Maladaptation to evidence-based HF prescription and the higher prevalence of cardiovascular risk factors in younger patients were among the possible issues to be addressed to improve the HF outcome in regions with similar socioeconomic background.
No takes yet. Share an insight, caveat, or question.
Ling et al. (2020) conducted an observational in Acute decompensated heart failure (n=107). Acute decompensated heart failure was evaluated on 90-day all-cause mortality. Among patients admitted with acute decompensated heart failure in a Malaysian non-cardiology tertiary center, the in-hospital mortality was 7.5% and 90-day all-cause mortality was 16.8%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: